These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 31359052)

  • 1. Comparison of Zebrafish Larvae and hiPSC Cardiomyocytes for Predicting Drug-Induced Cardiotoxicity in Humans.
    Dyballa S; Miñana R; Rubio-Brotons M; Cornet C; Pederzani T; Escaramis G; Garcia-Serna R; Mestres J; Terriente J
    Toxicol Sci; 2019 Oct; 171(2):283-295. PubMed ID: 31359052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An impedance-based approach using human iPSC-derived cardiomyocytes significantly improves in vitro prediction of in vivo cardiotox liabilities.
    Koci B; Luerman G; Duenbostell A; Kettenhofen R; Bohlen H; Coyle L; Knight B; Ku W; Volberg W; Woska JR; Brown MP
    Toxicol Appl Pharmacol; 2017 Aug; 329():121-127. PubMed ID: 28546047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moving beyond the comprehensive in vitro proarrhythmia assay: Use of human-induced pluripotent stem cell-derived cardiomyocytes to assess contractile effects associated with drug-induced structural cardiotoxicity.
    Yang X; Papoian T
    J Appl Toxicol; 2018 Sep; 38(9):1166-1176. PubMed ID: 29484688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ZeGlobalTox: An Innovative Approach to Address Organ Drug Toxicity Using Zebrafish.
    Cornet C; Calzolari S; Miñana-Prieto R; Dyballa S; van Doornmalen E; Rutjes H; Savy T; D'Amico D; Terriente J
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28422076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bridging Functional and Structural Cardiotoxicity Assays Using Human Embryonic Stem Cell-Derived Cardiomyocytes for a More Comprehensive Risk Assessment.
    Clements M; Millar V; Williams AS; Kalinka S
    Toxicol Sci; 2015 Nov; 148(1):241-60. PubMed ID: 26259608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CardioMotion: identification of functional and structural cardiotoxic liabilities in small molecules through brightfield kinetic imaging.
    Stebbeds W; Raniga K; Standing D; Wallace I; Bayliss J; Brown A; Kasprowicz R; Dalmas Wilk D; Deakyne J; Clements P; Chaudhary KW; Rossman EI; Bahinski A; Francis J
    Toxicol Sci; 2023 Aug; 195(1):61-70. PubMed ID: 37462734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Automated Platform for Assessment of Congenital and Drug-Induced Arrhythmia with hiPSC-Derived Cardiomyocytes.
    McKeithan WL; Savchenko A; Yu MS; Cerignoli F; Bruyneel AAN; Price JH; Colas AR; Miller EW; Cashman JR; Mercola M
    Front Physiol; 2017; 8():766. PubMed ID: 29075196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human cardiotoxic drugs delivered by soaking and microinjection induce cardiovascular toxicity in zebrafish.
    Zhu JJ; Xu YQ; He JH; Yu HP; Huang CJ; Gao JM; Dong QX; Xuan YX; Li CQ
    J Appl Toxicol; 2014 Feb; 34(2):139-48. PubMed ID: 23307606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
    Liang P; Lan F; Lee AS; Gong T; Sanchez-Freire V; Wang Y; Diecke S; Sallam K; Knowles JW; Wang PJ; Nguyen PK; Bers DM; Robbins RC; Wu JC
    Circulation; 2013 Apr; 127(16):1677-91. PubMed ID: 23519760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An impedance-based cellular assay using human iPSC-derived cardiomyocytes to quantify modulators of cardiac contractility.
    Scott CW; Zhang X; Abi-Gerges N; Lamore SD; Abassi YA; Peters MF
    Toxicol Sci; 2014 Dec; 142(2):331-8. PubMed ID: 25237062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hiPSC-CM Monolayer Maturation State Determines Drug Responsiveness in High Throughput Pro-Arrhythmia Screen.
    da Rocha AM; Campbell K; Mironov S; Jiang J; Mundada L; Guerrero-Serna G; Jalife J; Herron TJ
    Sci Rep; 2017 Oct; 7(1):13834. PubMed ID: 29061979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-Throughput Cardiotoxicity Screening Using Mature Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Monolayers.
    Monteiro da Rocha A; Allan A; Block T; Creech J; Herron TJ
    J Vis Exp; 2023 Mar; (193):. PubMed ID: 37036202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Automated image analysis system for studying cardiotoxicity in human pluripotent stem cell-Derived cardiomyocytes.
    Cao L; der Meer ADV; Verbeek FJ; Passier R
    BMC Bioinformatics; 2020 May; 21(1):187. PubMed ID: 32408861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Targeted Metabolomics-Based Assay Using Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Identifies Structural and Functional Cardiotoxicity Potential.
    Palmer JA; Smith AM; Gryshkova V; Donley ELR; Valentin JP; Burrier RE
    Toxicol Sci; 2020 Apr; 174(2):218-240. PubMed ID: 32040181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Throughput Measurement of Ca++ Dynamics in Human Stem Cell-Derived Cardiomyocytes by Kinetic Image Cytometery: A Cardiac Risk Assessment Characterization Using a Large Panel of Cardioactive and Inactive Compounds.
    Lu HR; Whittaker R; Price JH; Vega R; Pfeiffer ER; Cerignoli F; Towart R; Gallacher DJ
    Toxicol Sci; 2015 Dec; 148(2):503-16. PubMed ID: 26358003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput screening of tyrosine kinase inhibitor cardiotoxicity with human induced pluripotent stem cells.
    Sharma A; Burridge PW; McKeithan WL; Serrano R; Shukla P; Sayed N; Churko JM; Kitani T; Wu H; Holmström A; Matsa E; Zhang Y; Kumar A; Fan AC; Del Álamo JC; Wu SM; Moslehi JJ; Mercola M; Wu JC
    Sci Transl Med; 2017 Feb; 9(377):. PubMed ID: 28202772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In Vivo Cardiotoxicity Induced by Sodium Aescinate in Zebrafish Larvae.
    Liang J; Jin W; Li H; Liu H; Huang Y; Shan X; Li C; Shan L; Efferth T
    Molecules; 2016 Feb; 21(3):190. PubMed ID: 26907249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating nonlinear analysis and machine learning for human induced pluripotent stem cell-based drug cardiotoxicity testing.
    Kowalczewski A; Sakolish C; Hoang P; Liu X; Jacquir S; Rusyn I; Ma Z
    J Tissue Eng Regen Med; 2022 Aug; 16(8):732-743. PubMed ID: 35621199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human-induced pluripotent stem cell-derived cardiomyocytes, 3D cardiac structures, and heart-on-a-chip as tools for drug research.
    Andrysiak K; Stępniewski J; Dulak J
    Pflugers Arch; 2021 Jul; 473(7):1061-1085. PubMed ID: 33629131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of human induced pluripotent stem cell-derived cardiomyocytes to assess drug cardiotoxicity.
    Sharma A; McKeithan WL; Serrano R; Kitani T; Burridge PW; Del Álamo JC; Mercola M; Wu JC
    Nat Protoc; 2018 Dec; 13(12):3018-3041. PubMed ID: 30413796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.